{"id":147796,"date":"2025-04-25T12:31:09","date_gmt":"2025-04-25T07:01:09","guid":{"rendered":"https:\/\/tradebrains.in\/features\/?p=147796"},"modified":"2025-04-25T12:31:12","modified_gmt":"2025-04-25T07:01:12","slug":"pharma-stock-under-30-hits-upper-circuit-after-its-net-profits-increases-by-70-qoq","status":"publish","type":"post","link":"https:\/\/tradebrains.in\/features\/pharma-stock-under-30-hits-upper-circuit-after-its-net-profits-increases-by-70-qoq\/","title":{"rendered":"Pharma stock under \u20b930 hits upper circuit after its net profits increases by 70% QoQ"},"content":{"rendered":"<div class=\"trade-content_2\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-175025769\"><p><a href=\"https:\/\/tradebrains.in\/get\/telegram\/\"><img decoding=\"async\" class=\"alignnone wp-image-101992\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/01\/telegram-channel-300x119.png\" alt=\"\" width=\"148\" height=\"59\" \/><\/a> <a href=\"https:\/\/news.google.com\/publications\/CAAqBwgKMN3Epgswxc--Aw?hl=en-IN&amp;gl=IN&amp;ceid=IN%3Aen\"><img decoding=\"async\" class=\"alignnone wp-image-123430\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png\" alt=\"follow-on-google-news\" width=\"222\" height=\"61\" srcset=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png 300w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-150x41.png 150w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news.png 468w\" sizes=\"(max-width: 222px) 100vw, 222px\" \/><\/a><\/p>\n<\/div><p>The price of an indian penny pharma stock has hit a 2 percent upper circuit from the previous closing price as the company&#8217;s financial results show a robust Net profit growth of 70 percent QOQ and revenue growth of 21.5 percent.<\/p><div class=\"trade-content_7\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-2501839900\"><!-- Composite Start --> \r\n <div id=\"M923760ScriptRootC1549812\"> \r\n <\/div> \r\n <script src=\"https:\/\/jsc.mgid.com\/t\/r\/tradebrains.in.1549812.js\" async> \r\n <\/script> \r\n <!-- Composite End --><\/div><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Price action<\/strong><\/h2><p>With a market capitalization of Rs. 656.04 crores on Friday, the shares of <strong><a href=\"https:\/\/portal.tradebrains.in\/stocks\/543828\" target=\"_blank\" rel=\"noreferrer noopener\">Sudarshan Pharma Industries Ltd<\/a><\/strong>. were trading at CMP 27.80, which is close to 2 percent higher than its previous day&#8217;s closing price of Rs 27.26. The stock hit a 2 percent upper circuit today.<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>What Happened<\/strong><\/h2><p>Sudarshan Pharma Industries Ltd, a company engaged in the manufacturing of API and Pharmaceutical Items. , has announced its results for the Financial year \u201825.<\/p><p>Its Revenue grew by 20 percent YoY from Rs. 232 Crores in Q4FY24 to Rs. 277 Crores in Q4FY25, and it grew by 21.5 percent QoQ from Rs. 228 Crores in Q3FY25 to Rs. 277 Crores in Q4FY25.<\/p><div class=\"trade-content_5\" id=\"trade-2984755572\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_2_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"7925020301\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><p>Its Net Profit grew by 50 percent YoY from Rs. 6.60 Crores in Q4FY24 to Rs. 10 Crores in Q4FY25, but this includes an exponential income worth 1.65 crores obtained from the sale of an extended producer responsibility certificate. Excluding the exponential item, the net profit growth stands at&nbsp; 43 percent Year on year. The Net profits have grown by 70 percent QoQ from Rs. 5.92 Crores in Q3FY25 to Rs. 10 Crores in Q4FY25.<\/p><p>The company&#8217;s Earnings Before Interest, Depreciation, and Taxes (EBIDT) has also grown by 62 percent YOY from Rs 14.4 in Q4FY24 to Rs&nbsp; 23.4 in Q4FY25. Its<strong> <\/strong>EPS has also grown by 56 percent YOY from Rs. 0.27 in Q4FY24 to Rs. 0.42 in Q4FY25, and has increased by 68 percent QoQ from Rs. 0.25 in Q3FY25 to Rs. 0.42 in Q4FY25.<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>About the company<\/strong><\/h2><p>Sudarshan Pharma Industries Ltd manufactures API and Pharmaceutical Items. It also trades in Chemicals and Solvents. The Company carries&nbsp; Ethical marketing of Pharmaceutical formulation &amp; products in the Domestic and International markets through a distribution network and Sales force under its own brand.<\/p><p>It is also involved in Contract Manufacturing, outsourcing, &amp; Supply of Generic Pharma formulation and medicines to healthcare institutions, Government, NGO, and Hospitals. It also offers services of QC and Formulation Development to provide customised solutions to our customers and assist them in sourcing innovative products as per their needs.<\/p><blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p><strong>Written by Likesh Babu S<\/strong><\/p><\/blockquote><p class=\"has-medium-font-size\"><strong>Disclaimer<\/strong><\/p><div class=\"wp-block-image\"><figure class=\"aligncenter size-medium\"><img decoding=\"async\" width=\"300\" height=\"300\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/02\/warning-disclaimer-300x300.png\" alt=\"\" class=\"wp-image-26306\"\/><\/figure><\/div><p><strong>The views and investment tips expressed by investment experts\/broking houses\/rating agencies on <a href=\"http:\/\/tradebrains.in\/\">tradebrains.in<\/a> are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing<\/strong>.<\/p><div class=\"trade-content-10\" id=\"trade-4028033008\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_3_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"2969612066\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><div class=\"trade-after-content\" id=\"trade-3565183967\"><div id=\"taboola-below-article-thumbnails\"><\/div>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({\r\n    mode: 'alternating-thumbnails-a',\r\n    container: 'taboola-below-article-thumbnails',\r\n    placement: 'Below Article Thumbnails',\r\n    target_type: 'mix'\r\n  });\r\n<\/script>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({flush: true});\r\n<\/script><\/div>","protected":false},"excerpt":{"rendered":"<p>The price of an indian penny pharma stock has hit a 2 percent upper circuit from the previous closing price as the company&#8217;s financial results show a robust Net profit growth of 70 percent QOQ and revenue growth of 21.5 percent. Price action With a market capitalization of Rs. 656.04 crores on Friday, the shares [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":49884,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[31,1789],"tags":[6616,948,936,2597],"class_list":["post-147796","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-trending-news","tag-pharma-stock","tag-stock-market","tag-stock-market-news","tag-stocks-to-watch"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.5 (Yoast SEO v25.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Pharma stock under \u20b930 hits upper circuit after its net profits increases by 70% QoQ - Trade Brains Features<\/title>\n<meta name=\"description\" content=\"The price of an indian penny pharma stock has hit a 2 percent upper circuit from the previous closing price as the company&#039;s financial results show a robust Net profit growth of 70 percent QOQ and revenue growth of 21.5 percent.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/tradebrains.in\/features\/pharma-stock-under-30-hits-upper-circuit-after-its-net-profits-increases-by-70-qoq\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pharma stock under \u20b930 hits upper circuit after its net profits increases by 70% QoQ\" \/>\n<meta property=\"og:description\" content=\"The price of an indian penny pharma stock has hit a 2 percent upper circuit from the previous closing price as the company&#039;s financial results show a robust Net profit growth of 70 percent QOQ and revenue growth of 21.5 percent.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/tradebrains.in\/features\/pharma-stock-under-30-hits-upper-circuit-after-its-net-profits-increases-by-70-qoq\/\" \/>\n<meta property=\"og:site_name\" content=\"Trade Brains Features\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/TradeBrainsOfficial\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-04-25T07:01:09+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-04-25T07:01:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/06\/Pharma-1-Cover-Image.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"854\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Trade Brains\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:site\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Trade Brains\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-under-30-hits-upper-circuit-after-its-net-profits-increases-by-70-qoq\/\",\"url\":\"https:\/\/tradebrains.in\/features\/pharma-stock-under-30-hits-upper-circuit-after-its-net-profits-increases-by-70-qoq\/\",\"name\":\"Pharma stock under \u20b930 hits upper circuit after its net profits increases by 70% QoQ - Trade Brains Features\",\"isPartOf\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-under-30-hits-upper-circuit-after-its-net-profits-increases-by-70-qoq\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-under-30-hits-upper-circuit-after-its-net-profits-increases-by-70-qoq\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/06\/Pharma-1-Cover-Image.jpg\",\"datePublished\":\"2025-04-25T07:01:09+00:00\",\"dateModified\":\"2025-04-25T07:01:12+00:00\",\"author\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\"},\"description\":\"The price of an indian penny pharma stock has hit a 2 percent upper circuit from the previous closing price as the company's financial results show a robust Net profit growth of 70 percent QOQ and revenue growth of 21.5 percent.\",\"breadcrumb\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-under-30-hits-upper-circuit-after-its-net-profits-increases-by-70-qoq\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/tradebrains.in\/features\/pharma-stock-under-30-hits-upper-circuit-after-its-net-profits-increases-by-70-qoq\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-under-30-hits-upper-circuit-after-its-net-profits-increases-by-70-qoq\/#primaryimage\",\"url\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/06\/Pharma-1-Cover-Image.jpg\",\"contentUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/06\/Pharma-1-Cover-Image.jpg\",\"width\":1280,\"height\":854},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-under-30-hits-upper-circuit-after-its-net-profits-increases-by-70-qoq\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/tradebrains.in\/features\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pharma stock under \u20b930 hits upper circuit after its net profits increases by 70% QoQ\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/tradebrains.in\/features\/#website\",\"url\":\"https:\/\/tradebrains.in\/features\/\",\"name\":\"Trade Brains\",\"description\":\"Stock Market NSE\/BSE Latest News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/tradebrains.in\/features\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\",\"name\":\"Trade Brains\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"caption\":\"Trade Brains\"},\"sameAs\":[\"http:\/\/tradebrains.in\/\"],\"url\":\"https:\/\/tradebrains.in\/features\/author\/trade-brains\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Pharma stock under \u20b930 hits upper circuit after its net profits increases by 70% QoQ - Trade Brains Features","description":"The price of an indian penny pharma stock has hit a 2 percent upper circuit from the previous closing price as the company's financial results show a robust Net profit growth of 70 percent QOQ and revenue growth of 21.5 percent.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/tradebrains.in\/features\/pharma-stock-under-30-hits-upper-circuit-after-its-net-profits-increases-by-70-qoq\/","og_locale":"en_US","og_type":"article","og_title":"Pharma stock under \u20b930 hits upper circuit after its net profits increases by 70% QoQ","og_description":"The price of an indian penny pharma stock has hit a 2 percent upper circuit from the previous closing price as the company's financial results show a robust Net profit growth of 70 percent QOQ and revenue growth of 21.5 percent.","og_url":"https:\/\/tradebrains.in\/features\/pharma-stock-under-30-hits-upper-circuit-after-its-net-profits-increases-by-70-qoq\/","og_site_name":"Trade Brains Features","article_publisher":"https:\/\/www.facebook.com\/TradeBrainsOfficial\/","article_published_time":"2025-04-25T07:01:09+00:00","article_modified_time":"2025-04-25T07:01:12+00:00","og_image":[{"width":1280,"height":854,"url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/06\/Pharma-1-Cover-Image.jpg","type":"image\/jpeg"}],"author":"Trade Brains","twitter_card":"summary_large_image","twitter_creator":"@TradeBrainsGrp","twitter_site":"@TradeBrainsGrp","twitter_misc":{"Written by":"Trade Brains","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-under-30-hits-upper-circuit-after-its-net-profits-increases-by-70-qoq\/","url":"https:\/\/tradebrains.in\/features\/pharma-stock-under-30-hits-upper-circuit-after-its-net-profits-increases-by-70-qoq\/","name":"Pharma stock under \u20b930 hits upper circuit after its net profits increases by 70% QoQ - Trade Brains Features","isPartOf":{"@id":"https:\/\/tradebrains.in\/features\/#website"},"primaryImageOfPage":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-under-30-hits-upper-circuit-after-its-net-profits-increases-by-70-qoq\/#primaryimage"},"image":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-under-30-hits-upper-circuit-after-its-net-profits-increases-by-70-qoq\/#primaryimage"},"thumbnailUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/06\/Pharma-1-Cover-Image.jpg","datePublished":"2025-04-25T07:01:09+00:00","dateModified":"2025-04-25T07:01:12+00:00","author":{"@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666"},"description":"The price of an indian penny pharma stock has hit a 2 percent upper circuit from the previous closing price as the company's financial results show a robust Net profit growth of 70 percent QOQ and revenue growth of 21.5 percent.","breadcrumb":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-under-30-hits-upper-circuit-after-its-net-profits-increases-by-70-qoq\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/tradebrains.in\/features\/pharma-stock-under-30-hits-upper-circuit-after-its-net-profits-increases-by-70-qoq\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-under-30-hits-upper-circuit-after-its-net-profits-increases-by-70-qoq\/#primaryimage","url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/06\/Pharma-1-Cover-Image.jpg","contentUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/06\/Pharma-1-Cover-Image.jpg","width":1280,"height":854},{"@type":"BreadcrumbList","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-under-30-hits-upper-circuit-after-its-net-profits-increases-by-70-qoq\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/tradebrains.in\/features\/"},{"@type":"ListItem","position":2,"name":"Pharma stock under \u20b930 hits upper circuit after its net profits increases by 70% QoQ"}]},{"@type":"WebSite","@id":"https:\/\/tradebrains.in\/features\/#website","url":"https:\/\/tradebrains.in\/features\/","name":"Trade Brains","description":"Stock Market NSE\/BSE Latest News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/tradebrains.in\/features\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666","name":"Trade Brains","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","caption":"Trade Brains"},"sameAs":["http:\/\/tradebrains.in\/"],"url":"https:\/\/tradebrains.in\/features\/author\/trade-brains\/"}]}},"_links":{"self":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/147796","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/comments?post=147796"}],"version-history":[{"count":1,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/147796\/revisions"}],"predecessor-version":[{"id":147797,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/147796\/revisions\/147797"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media\/49884"}],"wp:attachment":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media?parent=147796"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/categories?post=147796"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/tags?post=147796"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}